4.7 Letter

The J-shaped relationship between body mass index and mortality in patients with COVID-19: A dose-response meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis

R. Pranata et al.

Summary: This meta-analysis revealed a dose-response relationship between body mass index (BMI) and poor outcome in patients with COVID-19, indicating that an increase in BMI is associated with an increased risk of poor outcomes.

DIABETES & METABOLISM (2021)

Letter Endocrinology & Metabolism

Obese COVID-19 patients show more severe pneumonia lesions on CT chest imaging

Xiao Luo et al.

DIABETES OBESITY & METABOLISM (2021)

Article Endocrinology & Metabolism

Relationship between obesity and severe COVID-19 outcomes in patients with type 2 diabetes: Results from the CORONADO study

Sarra Smati et al.

Summary: The study showed that overweight and obesity are linked to poor early prognosis in T2D patients hospitalized for COVID-19, especially in those under the age of 75. The negative impact of obesity on COVID-19 prognosis was not observed in elderly patients aged over 75, indicating a need for specific management in this population.

DIABETES OBESITY & METABOLISM (2021)

Article Endocrinology & Metabolism

Association of body mass index (BMI) with critical COVID-19 and in-hospital mortality: A dose-response meta-analysis

Yanbin Du et al.

Summary: This study examined the association between BMI and COVID-19 severity and mortality through a meta-analysis of 16 observational studies involving 109,881 patients. The findings showed a linear dose-response relationship between BMI and critical COVID-19 and mortality, with patients with BMI > 30 kg/m(2) at higher risk. Age and obesity were also found to impact this association.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Article Rheumatology

Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients

Florence Aeschlimann et al.

Summary: In this French cohort study of RMD COVID-19 patients, older age, male gender, obesity, and hypertension were found to be associated with severe COVID-19, similar to the general population. Patients with iRMD on corticosteroids, but not methotrexate, tumor necrosis factor alpha, and interleukin-6 inhibitors, were more likely to develop severe COVID-19. Unlike common comorbidities, such as obesity, cardiovascular or lung diseases, the risk of death in patients with iRMD was not significantly increased.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Cardiac & Cardiovascular Systems

Association of Body Mass Index and Age With Morbidity and Mortality in Patients Hospitalized With COVID-19 Results From the American Heart Association COVID-19 Cardiovascular Disease Registry

Nicholas S. Hendren et al.

Summary: This study found that obese patients are more likely to be hospitalized with COVID-19, and are at higher risk of in-hospital death or mechanical ventilation, particularly if young (age <= 50 years). Additionally, obese patients are also at higher risk for venous thromboembolism and dialysis. These observations support clear public health messaging and rigorous adherence to COVID-19 prevention strategies in all obese individuals regardless of age.

CIRCULATION (2021)

Article Endocrinology & Metabolism

BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID-19 in New York

Tara S. Kim et al.

Summary: This study found that patients with COVID-19 who were overweight or obese had an increased risk of requiring invasive mechanical ventilation, while underweight and obese patients had an increased risk of death. Pulmonary complications seem to be significant contributors to poor outcomes in COVID-19 infection.

OBESITY (2021)

Article Endocrinology & Metabolism

Obesity as a driver of international differences in COVID-19 death rates

Julian Gardiner et al.

Summary: The study found that 63% of the inter-country variation in COVID-19 death rates can be explained by differences in obesity rates, population health, population densities, age demographics, delays in imposing national virus control measures, per capita GDP, and climate. It is suggested that some of the unexplained variation may be due to differences in how countries define COVID-19 deaths and the completeness of recording these deaths.

DIABETES OBESITY & METABOLISM (2021)

Article Multidisciplinary Sciences

In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation

Antonio Olivas-Martinez et al.

Summary: The high in-hospital death rate among severe COVID-19 patients in Mexico is associated with risk factors such as male sex, obesity, and low oxygen saturation on admission. Lack of ICU beds resulted in some patients not receiving necessary support, indirectly contributing to hospital mortality.

PLOS ONE (2021)

Article Endocrinology & Metabolism

Clinical characteristics and outcomes in women and men hospitalized for coronavirus disease 2019 in New Orleans

Yilin Yoshida et al.

Summary: This study found differences in clinical characteristics and outcomes of COVID-19 patients based on gender, with women more commonly presenting with obesity, hypertension, diabetes, and respiratory symptoms, and men showing higher risk factors for severe outcomes such as elevated D-dimer levels. These findings may help tailor management and prevention strategies for better gender-specific outcomes.

BIOLOGY OF SEX DIFFERENCES (2021)

Article Critical Care Medicine

Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study

Matthieu Schmidt et al.

Summary: Among more than 4000 critically ill patients with COVID-19 admitted to our ICUs, 90-day mortality was 31% and decreased from 42 to 25% over the study period. Mortality was higher in older, diabetic, obese and severe ARDS patients.

INTENSIVE CARE MEDICINE (2021)

Article Endocrinology & Metabolism

Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City

Kaveh Hajifathalian et al.

OBESITY (2020)

Article Medicine, General & Internal

Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization

Sara Y. Tartof et al.

ANNALS OF INTERNAL MEDICINE (2020)

Letter Medicine, General & Internal

Obesity and COVID-19 in New York City: A Retrospective Cohort Study

Parag Goyal et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection A Retrospective Cohort Study

Michaela R. Anderson et al.

ANNALS OF INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Demographics, comorbidities and outcomes in hospitalized Covid-19 patients in rural southwest Georgia

Priyank Shah et al.

ANNALS OF MEDICINE (2020)

Letter Endocrinology & Metabolism

Body mass index and the risk ofCOVID-19 across ethnic groups: Analysis ofUKBiobank

Cameron Razieh et al.

DIABETES OBESITY & METABOLISM (2020)

Article Medicine, General & Internal

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Shruti Gupta et al.

JAMA INTERNAL MEDICINE (2020)

Article Endocrinology & Metabolism

The impact of obesity on COVID-19 complications: a retrospective cohort study

Mohamed Nakeshbandi et al.

INTERNATIONAL JOURNAL OF OBESITY (2020)

Review Endocrinology & Metabolism

Obesity and mortality of COVID-19. Meta-analysis

Abdulzahra Hussain et al.

OBESITY RESEARCH & CLINICAL PRACTICE (2020)

Review Endocrinology & Metabolism

Obesity in patients with COVID-19: a systematic review and meta-analysis

Yi Huang et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Article Environmental Sciences

Analysis of Mortality and Morbidity in COVID-19 Patients with Obesity Using Clinical Epidemiological Data from the Korean Center for Disease Control & Prevention

So Young Kim et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Review Medicine, General & Internal

Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories A Systematic Review and Meta-analysis

Katherine M. Flegal et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Editorial Material Endocrinology & Metabolism

Does Being Overweight Really Reduce Mortality?

Deirdre K. Tobias et al.

OBESITY (2013)

Article Public, Environmental & Occupational Health

Meta-Analysis for Linear and Nonlinear Dose-Response Relations: Examples, an Evaluation of Approximations, and Software

Nicola Orsini et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)

Article Mathematical & Computational Biology

Dose-response analyses using restricted cubic spline functions in public health research

Loic Desquilbet et al.

STATISTICS IN MEDICINE (2010)

Article Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

ANNALS OF INTERNAL MEDICINE (2009)

Article Medicine, General & Internal

Measuring inconsistency in meta-analyses

JPT Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2003)